Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Insights Into Cancer Chronotherapies
Jingxuan Zhou, Jiechen Wang, Xiaozhao Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives
Amusa S. Adebayo, Kafilat Agbaje, Simeon K. Adesina, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2620-2620
Open Access | Times Cited: 42
Circadian Regulation of Drug Responses: Toward Sex-Specific and Personalized Chronotherapy
Françis Lévi, Alper Okyar, Éva Hadadi, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 89-114
Open Access | Times Cited: 33
The Relationship between Circadian Rhythm and Cancer Disease
Camelia Munteanu, Sabina Turti, Larisa Achim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5846-5846
Open Access | Times Cited: 13
Significant impact of time-of-day variation on metformin pharmacokinetics
Denise Türk, Nina Scherer, Dominik Selzer, et al.
Diabetologia (2023) Vol. 66, Iss. 6, pp. 1024-1034
Open Access | Times Cited: 15
Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations
Nojoud Al-Ansari, Samson Mathews Samuel, Dietrich Büsselberg
Biomolecules (2024) Vol. 14, Iss. 2, pp. 145-145
Open Access | Times Cited: 6
Obesity, cancer risk, and time-restricted eating
Manasi Das, Nicholas J. G. Webster
Cancer and Metastasis Reviews (2022) Vol. 41, Iss. 3, pp. 697-717
Open Access | Times Cited: 21
Heterogeneity in precision oncology
Bartłomiej Tomasik, Filip Garbicz, Marcin Braun, et al.
Cambridge Prisms Precision Medicine (2023), pp. 1-37
Open Access | Times Cited: 11
Multi-omics and single-cell sequencing analyses reveal the potential significance of circadian pathways in cancer therapy
Hao Lai, Xiaoyun Xiang, Xingqing Long, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 1-2, pp. 107-121
Closed Access | Times Cited: 4
The role of circadian rhythm regulator PERs in oxidative stress, immunity, and cancer development
Baisuo Zhao, Eugenie Nepovimová, Qinghua Wu
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Bibliometric analysis of global research status and trends of circadian rhythms in cancer from 2004 to 2024
Zhihong Chen, Shitao Jiang, Y. Liu, et al.
Chronobiology International (2025), pp. 1-13
Open Access
Personalization of Cancer Treatment: Exploring the Role of Chronotherapy in Immune Checkpoint Inhibitor Efficacy
Rosalyn M. Fey, Avery Billo, Terri Clister, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 732-732
Open Access
A combined mathematical and experimental approach reveals the drivers of time-of-day drug sensitivity in human cells
Nica Gutu, Hitoshi Ishikuma, Carolin Ector, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Can we utilise the circadian clock to target cancer stem cells?
Jia-Wen Lian, Shi-Yang Li, Robert B. Clarke, et al.
Cancer Letters (2024), pp. 217360-217360
Open Access | Times Cited: 2
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
Eva Ramos, Javier Egea, Francisco López‐Muñoz, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1616-1616
Open Access | Times Cited: 5
Biological rhythms and epilepsy treatment
Jon Andreas Rugstad Næsgaard, Leif Gjerstad, Kjell Heuser, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 5
Circadian rhythm-based cancer therapy in randomised clinical trials
Loredana G. Marcu
Expert Review of Anticancer Therapy (2023) Vol. 24, Iss. 1-2, pp. 29-39
Closed Access | Times Cited: 5
Chronotherapeutics in the management of oral squamous cell carcinoma – A futuristic novel treatment strategy
P Poornachitra, Arvind Muthukrishnan, Devaraj Ezhilarasan
Indian Journal of Cancer (2024)
Open Access | Times Cited: 1
Chronopharmacology in cancer treatment: Optimizing drug timing for improved efficacy and reduced toxicity
Redlin Jani Rajan, Dhivyaprasath Palaniappan
Open Access Research Journal of Biology and Pharmacy (2024) Vol. 10, Iss. 2, pp. 001-012
Open Access | Times Cited: 1
Integrating AI-driven Wearable Technology in Oncology Decision Making: A Narrative Review
Meghna Birla, Rajan, Prabhat Gautam Roy, et al.
Oncology (2024), pp. 1-13
Open Access | Times Cited: 1
Period2 is associated with immune cell infiltration and is a potential diagnostic and prognostic marker for hepatocellular carcinoma
Xiaolin Chen, Qiaosu Zhao, Haibiao Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
Bedeutung des circadianen Rhythmus für organisch bedingte Erkrankungen
Alfred Wiater
Elsevier eBooks (2024), pp. 71-94
Closed Access
Circadian rhythm and body health: A review of the literatur
Shahrzad Sadat Eftekhar Vaghefi, Reza Malekpour Afshar, Fatemeh Shahsavari, et al.
Deleted Journal (2024) Vol. 28, Iss. 3, pp. 237-256
Open Access
References

Immune system (2024), pp. 471-578
Closed Access
Lifestyle Factors Affecting Biological Processes and Health
Hymie Anisman, Shawn Hayley, Alexander W. Kusnecov
Immune system (2024), pp. 99-129
Closed Access
Cancer-new therapies aligned with Homoeopathy
Tridibesh Tripathy, Shankar Das, Niranjan Mohanty, et al.
International Journal of Research in Medical Sciences (2024) Vol. 13, Iss. 1, pp. 564-570
Open Access
Page 1 - Next Page

Scroll to top